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ABSTRACT 
 
Twelve different vaccines were prepared from hydropericardium syndrome (HPS) infected liver 
homogenate by using two different virus concentrations (1x10
2 and 1x10
3 ALD50) and two virus inactivants 
(0.1% formalin  and 0.01% binary ethyleneimine) with and with out different adjuvants. These vaccines 
were evaluated in 13 groups of broilers (8 in each group) for their comparative immunogenicity and 
protection. At day 14 of age, chicks of groups A1, B1, C1 and D1 were vaccinated with 4 oil based 
vaccines (OB-HPSV) with two different virus concentrations (1x10
2 &
 1x10
3 ALD50) and two different 
inactivants (0.1% formalin  and 0.01% binary ethyleneimine), respectively. Chicks of groups A2, B2, C2 
and D2 were vaccinated with 4  aluminized vaccines (AH-HPSV) using two virus concentrations and two 
inactivants. Similarly, chicks of groups A3, B3, C3 and D3 were vaccinated with non adjuvanted vaccines 
(NA-HPSV) with two virus concentrations and two inactivants. Group E was kept as unvaccinated control.  
All the vaccinated birds were found sero-positive 7 days post vaccination (PV). IHA GMT results indicated 
no difference for different virus concentrations and different virus inactivants with same adjuvant (P>0.05). 
The IHA GMT recorded weekly during 0-28 days PV was the highest and more consistent (52-181) for 
OB-HPSV, followed by AH-HPSV (52-147) and NA-HPSV (73.3-104). The protection recorded for OB-
HPSV vaccine was 100%, for AH-HPSV vaccine it 87.5% and with NA-HPSV vaccine it was 62.5% when 
challenged at 21 days post vaccination (PV). It was concluded that 1x10
2 ALD50  oil based vaccines 
inactivated with either formalin or binary ethyleneimine can be recommended for commercial use.  
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INTRODUCTION 
 
Hydropericardium syndrome, (HPS), also known 
as Angara disease, is a common viral disease of 
growing broilers (3-5 weeks of age). This disease is 
caused by avian adenovirus serotype-4 (Rabbani and 
Naeem, 1996) and characterized by high morbidity and 
mortality (up to 80%), with hydropericardium, necrosed 
and enlarged pale liver, enteritis, reactive spleen, 
congestion of lungs, haemorrhages on heart and kidneys 
as major post mortem findings (Anonymous, 1988; 
Chishti et al., 1989; Rabbani et al.,1998). In Pakistan, 
first out break of HPS occurred at Angara Goth, near 
Karachi in August, 1987. During 1989, more than 25% 
of broiler farms were closed due to this disease and 
losses due to HPS were estimated as more than Rs. 80 
billions/annum (Khalid, 2003). HPS was first 
characterized as a hydropericardium-pulmonary edema 
with hepato-nephritis (Anonymous, 1988). Later 
Rabbani (1997) suggested the etiopathological name of 
the disease as infectious hydro-pericarditis-hepatitis 
syndrome (IHH).  
Diagnosis of the disease before the appearance of 
symptoms is difficult since the birds do not show 
specific clinical signs. Sudden mortality at the third 
week of age and necropsy findings such as 
hydropericardium and demonstration of basophilic 
intranuclear inclusion bodies in hepatocytes are 
considered as pathognomonic. Indirect haemagglu- 
tination assay (IHA), enzyme linked immunosorbant 
assay (ELISA), agar gel precipitation test (AGPT), 
virus neutralization test (VN), dot immunobinding 
assay (DIA) and immuno-electrophoresis using infected 
liver homogenate filtrate as crude antigen, with specific 
antiserum have also been used in HPS diagnosis 
(Rabbani, 1997).  
Standard vaccines are available against most of the 
poultry diseases, but the literature regarding the 
standard protocols for development and evaluation of 
avian HPS virus vaccines have been scanty. Therefore, 
the present project was designed to produce HPS virus 
vaccines from infected liver homogenate using two 
virus inactivants, with and with out different adjuvants. 
These vaccines were evaluated in experimental broilers 
for their comparative immunogenicity and protection.  
 
MATERIALS AND METHODS 
 
Three weeks old broilers chicks (n = 21) were 
purchased from market and shifted to the experimental Pakistan Vet. J., 2008, 28(4): 163-166. 
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shed of the Department of Microbiology, University of 
Veterinary and Animal Sciences (UVAS), Lahore, 
Pakistan. On day 26 of age, 15 birds were challenged 
with virulent hydropericardium syndrome (HPS) virus 
from frozen virus seed (obtained from University 
Diagnostic Laboratory, UVAS, Lahore) and remaining 
6 birds were kept as non challenged control. Birds were 
observed for 5 days post challenge (PC) for any 
mortality and the results were recorded. The moribund 
livers of HPS infected dead birds were removed, placed 
in containers and stored at -20
0 C.  
One gram of HPS virus infected liver was 
homogenized in an electric homogenizer with 9 ml of 
normal saline (pH 7.2) and centrifuged at 3000 rpm for 
10 minutes. The clear supernatant was taken out and 
Gentamycin @ 200 ug/ml, Penicillin @ 1000 i.u./ml 
and Streptomycin @ 100 ug/ml were added to the 
supernatant fluid (Hussain et al., 1996). This 10% 
infected liver homogenate was processed for 
determination of animal lethal dose 50 (ALD50), as 
described by Reed and Muench (1938).  
Infected liver homogenate (10%) was diluted to 
achieve virus suspensions having 1x10
2 and 1x10
3 
ALD50 HPS virus and inactivated by using formalin in 
the ratio of 1:1000 (Saif, 2003) and 0.001M binary 
ethyleneimine (BEI) in ratio of 1:10,000 (Anonymous, 
1988). Each of the inactivated virus suspension was 
subjected to safety and sterility testing, as described by 
Khalid (2003). 
Formalin inactivated virus suspensions (1x10
2 and 
1x10
3 ALD50) were processed for vaccine preparation 
by admixing each virus suspension in ratio of 2:3 with 
oil base (span 80 = 7 parts, tween 80 = 3 parts and 
liquid paraffine = 90 parts), aluminium hydroxide gel 
(Malik, 2003) and no adjuvant and following 6 vaccines 
were prepared: (i) Formalized 1x10
2 ALD50 oil base 
HPS vaccine (F-OB-HPSV-1), (ii) Formalized 1x10
2 
ALD50 aluminized HPS vaccine (F-AH-HPSV-1), (iii) 
Formalized 1x10
2 ALD50 no adjuvant HPS vaccine (F-
NA-HPSV-1), (iv) Formalized 1x10
3 ALD50 oil base 
HPS vaccine (F-OB-HPSV-2), (v) Formalized 1x10
3 
ALD50 aluminized HPS vaccine (F-AH-HPSV-2) and 
(vi) Formalized 1x10
3 ALD50 no adjuvant HPS vaccine 
(F-NA-HPSV-2).  
Similarly, binary ethyleneimine (BEI) inactivated 
virus suspensions (1x10
2 and 1x10
3 ALD50) were 
admixed with oil base, aluminium hydroxide gel and no 
adjuvant and following 6 vaccines were again prepared; 
(i) BEI inactivated 1x10
2 ALD50 oil base HPS vaccine 
(BEI-OB-HPSV-1), (ii) BEI inactivated 1x10
2 ALD50 
aluminized HPS vaccine (BEI-AH-HPSV-1), (iii) BEI 
inactivated 1x10
2 ALD50  no adjuvant HPS vaccine 
(BEI-NA-HPSV-1), (iv) BEI inactivated 1x10
3 ALD50 
oil base HPS vaccine (BEI-OB-HPSV-2), (v) BEI 
inactivated 1x10
3 ALD50 aluminized HPS vaccine (BEI 
-AH-HPSV-2 and (vi) BEI inactivated 1x10
3 ALD50 no 
adjuvant HPS vaccine (BEI-NA-HPSV-2). 
For evaluation of these 12 vaccines, 104 day-old 
broiler chicks were purchased from market and divided 
into 13 groups (each having 8 chicks). Birds of each 
group were marked and vaccinated at 14
th day of age 
with 0.5 ml of vaccine subcutaneously as shown in 
Table 1. Birds of group-E were kept as non vaccinated 
control. Blood was collected randomly from 4 birds of 
each group weekly after vaccination (AV) up to 4 
weeks, serum was separated and heated at 56
0C for 40 
minutes to inactivate complement. Each serum sample 
was subjected to indirect haemagglutination assay 
(IHA) and geometric mean titer (GMT) for each group 
was calculated. On day 35 of age (21 days AV), all the 
birds were given challenge dose of virulent HPS virus 
(1 ml 40% w/v infected liver homogenate). Mortality 
and morbidity of all challenged birds were recorded up 
to 7 days post challenge (PC) and the relationship of 
IHA GMT with susceptibility was determined. Analysis 
of variance and DMR test were applied using SPSS 
software. 
 
Table 1: Vaccination schedule for birds of different 
groups 
E*= control non vaccinated group. 
 
RESULTS AND DISCUSSION 
 
HPS was reproduced in three weeks old broilers 
(not vaccinated against HPS) by injecting 40% w/v 
infected liver homogenate. After 42 hours, mortality 
started and reached to its peak 70-90 hours post 
challenge (PC). Dead birds showed characteristic 
hydropericardium with enlarged, pale, necrosed liver, 
congestion of lungs, enteritis and hemorrhages on heart 
and kidneys. These findings are congruent with those of 
Khwaja et al. (1988) and Anjum et al. (1989).  
HPS infected liver homogenate (10%) was tested 
against known antiserum through AGPT for 
confirmation of HPS agent. After 24 hrs of incubation, 
a clear precipitation band was observed (Kumar et al., 
1997). ALD50 was calculated as 10
-4.4/ml after this 
confirmation.  
Groups No  of 
chicks 
Vaccine Virus  concen- 
tration (ALD50) 
A1  8  F-OB-HPSV-1  1 x 10 
2 
A2  8  F-AH-HPSV-1  1 x 10 
2 
A3  8  F-NA-HPSV-1  1 x 10 
2 
B1  8  F-OB-HPSV-2  1 x 10 
3 
B2  8  F-AH-HPSV-2  1 x 10 
3 
B3  8  F-NA-HPSV-2  1 x 10 
3 
C1  8  BEI-OB-HPSV-1  1 x 10 
2 
C2  8  BEI-AH-HPSV-1  1 x 10 
2 
C3  8  BEI-NA-HPSV-1  1 x 10 
2 
D1  8  BEI-OB-HPSV-2  1 x 10 
3 
D2  8  BEI-AH-HPSV-2  1 x 10 
3 
D3  8  BEI-NA-HPSV-2  1 x 10 
3 
E* 8  Control   Pakistan Vet. J., 2008, 28(4): 163-166. 
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All birds vaccinated at day 14 of age were 
challenged with virulent HPS virus on day 35 of age 
and were observed for 7 days post challenge for 
mortality. Birds given oil based HPS vaccines (A1, B1, 
C1 and D1 groups) showed 0% mortality and 100% 
protection (Table 2). Birds vaccinated with aluminium 
hydroxide gel adjuvanted HPS vaccine (A2, B2, C2 and 
D2 groups) showed variable responses in terms of 
percent mortality and protection. The lowest mortality 
(0%) and highest protection percentage (100%) were 
recorded for group B2, C2 and D2, while in group A2 
there was 12.5 per cent mortality Table 2).  The 
protection percentage in vaccinated birds was found to 
be highest for oil based vaccine (100%), followed by 
aluminized vaccine (87.3-100 %) and non adjuvant 
vaccine (57.5%), when challenged with virulent virus 
inoculums at day 21 post-vaccination (PV). This may 
be due to higher antibody level in response to oil 
adjuvanted vaccine. These findings are in line with the 
observations of Hussain et al. (1996).  
All vaccinated birds were found sero-positive 7 
days AV when assayed by IHA. Hussain et al. (1996) 
and Noor-ul-Hassan et al. (1994) also found similar 
results, while Chishti et al. (1989) and Sarwar et al. 
(1995) reported seroconversion in 10-14 days after 
vaccination against HPS in broiler chickens. This 
difference in seroconversion rate is supposed to be due 
to composition of autogenous vaccines, breed of 
chickens, managemental condition, time of vaccination 
(bird immune status) or type of serological test.  
Statistical analysis showed that antibody titers at 
day 7 PV in groups A3, B3 and C3 (F-NA-HPSV) were 
significantly higher (73.3) than for other groups (Table 
3).  At day 14 PV, there was no significant difference in 
IHA GMT values of groups A1, A2, B1, B2, C1, C2 
and D1. The highest IHA GMT value (147) was 
recorded for these groups at day 14 PV. Similarly, the 
antibody titer was significantly higher for groups A1, 
B1, C1 and D1 than for other groups at day 21 PV. This 
highest antibody titer was maintained by groups A1, B1 
and C1 for next 7 days (28 days PV). These IHA GMT 
values reveal the highest value (73.3) for non adjuvant 
vaccine during 1-2 weeks AV; it started to decrease in 
3
rd week and dropped to 4.6, at 4
th week AV, probably 
due to immunity break (Afzal and Ahmad, 1990). This 
rapid increase and drop in GMT with non adjuvanted 
vaccine may be due to rapid absorption and rapid 
elimination of vaccinal agent. This is congruent with 
Hussain et al. (1999). The IHA GMT values at same 
time intervals for aluminized vaccine were 64, 128-147, 
104-147 and 73-112. IHA GMT values were highest 
and more consistent for oil based vaccines inactivated 
either with formalin or BEI with peak GMT (181) in 3
rd 
week AV (Hussain et al., 1999).   
So in this study, two different virus concentrations 
(1x10
2 and 1x10
3  ALD50 HPS antigen concentration) 
and two different virus inactivants (formalin and BEI ) 
were used. It appears that neither virus concentrations 
nor inactivants make any difference in terms of 
protection percentage and IHA GMT values using same 
adjuvant. Ahmad et  al. (1990) also recorded no 
difference in protection percentage and IHA GMT 
values of birds vaccinated with 5x10
1 or 1x 10
2.3 EID50 
HPS virus containing vaccines.  
From this study, it is concluded that oil based HPS 
vaccine containing 1x10
2  ALD50 HPS virus, inactivated 
with formalin or BEI provided 100% protection in birds 
vaccinated at 14
th day of age for at least 4-5 weeks AV. 
This vaccine can be recommended for commercial 
production. 
 
Table 2: Mortality and protection in challenged vaccinated groups (challenged on day 21 post vaccination) 
Groups  Days after virus 
challenge  A1 A2 A3 B1 B2 B3 C1 C2 C3 D1 D2 D3  E 
1  - - - - - - - - - - - - - 
2  - - - - - - - - - - - - - 
3  - - - - - - - - - - - 1 2 
4  - - 1 - - - - - 1 - - - - 
6  - - - - - - - - 1 - - 2 2 
7  - - 1 -  --  2 - - - - - - - 
8  - 1 - - - - - - - - - - 3 
9  - - - - - - - - - - - - - 
Total  0/8 1/8 2/8 0/8 0/8 2/8 0/8 0/8 2/8 0/8 0/8 3/8 7/8 
Mortality  (%)  0  12.5  25 0 0 25 0  0 25 0  0  37.5  87.5 
Protection  (%)  100 85.7 71.4 100 100 71.4 100 100 71.4 100 100  57  - 
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  Table 3: IHA GMT values at 7, 14, 21 and 28 days post vaccination (DPV) 
Formalized vaccine (F-HPSV)    BEI inactivated vaccine (BEI-HPSV) 
Virus con.= 1x10
2  
ALD50 
Virus con.= 1x10
3 
  
ALD50 
 
 
Virus con.=1x10
2   
ALD50 
Virus con.= 1x10
3 
ALD50   
IHA GMT 
antibody 
titers at 
intervals   A1 A2  A3  B1 B2 B3  C1  C2  C3  D1  D2  D3  E** 
7 days PV  52
a  52
 a 73.3
 c 52
 a 64
 b 73.3
 c 52
 a 64
 b 64
 b 64
 b 52
 a 73.3
 c 0 
14 days PV  147
 e 147
 e 84.4
 b 147
 e 147
 e 73.3
 a 147
 e 147
 e 104
 c 147
 e 128
 d 128
 d 0 
21days PV  181
 f 147
 e 36
 b 181
 f 128
 d 26
 a 181
 f 104
 c 26
 a 181
 f 104
 c 26
 a 0 
28 days PV  181
 h 104
 e 4.6
 b 181
 h 112
 f 2.3
 a 181
 h 90.5
 d 2.3
 a 147
 g 73.3
 c 2.3
 a 0 
Figures with different superscripts across the row are significantly different from each other (P<0.05).    
E** = Non vaccinated control group. 
GMT* = Geometric mean IHA titre of 4/8 random samples. 
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